Indeed, NLRP3 activation has been implicated in the development of many major diseases such as gout, type 2 diabetes, obesity-induced insulin resistance and depression [36, 37]. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.